United States · Seed startup

Who invested in Modulo Bio

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 26 Oct 2026

$4.8Mraised across 1 round since 2025, from 1 source

Latest round
Seed, $4.8MMar 2025
Investors
5
See who backed them

The rounds

  1. Mar 2025
    Seed$4.8M

    Source recordedSEC filing: $5.8M sold, first sale Nov 2024

Founders and team

From Modulo Bio's own website: 2 founders, 2 on the team.

Mike HorowitzCEO & Co-founder
Scott PattersonCTO & Co-founder
  • Apuleyo YanezResearch Associate
  • Hannah ZhengSenior Research Associate

Everyone who backed them

Initialized CapitalVC firm1round
Builders VCVC firm1round
Refactor CapitalVC firm1round
SpacecadetVC firm1round
CantosVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Modulo Bio

Who invested in Modulo Bio?

Modulo Bio's investors include Initialized Capital, Builders VC, Refactor Capital, Spacecadet and Cantos.

How much has Modulo Bio raised?

Modulo Bio has raised $4.8M across 1 round since 2025.

When did Modulo Bio last raise?

Modulo Bio's most recent round was a Seed of $4.8M in Mar 2025.

What was Modulo Bio's biggest round?

Its most recent round, $4.8M in Mar 2025, is also its largest on record.

Who backed Modulo Bio first?

Modulo Bio's first round on record, in Mar 2025, was backed by Initialized Capital, Builders VC and Refactor Capital and 2 others.

What stage is Modulo Bio at?

Modulo Bio's latest named round is a Seed, in Mar 2025.

Where is Modulo Bio based?

Modulo Bio is based in the United States.

Companies like Modulo Bio

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.